Topic

Insurance Approval

A collection of 712 issues

Xospata (Gilteritinib) Approval with UnitedHealthcare in Virginia: Answers to the Most Common Questions

Answer Box: Getting Xospata Covered by UnitedHealthcare in Virginia Xospata (gilteritinib) requires prior authorization from UnitedHealthcare for relapsed/refractory AML with confirmed FLT3 mutations. Fastest approval path: Submit PA with FDA-approved FLT3 test results, prior therapy documentation, and oncologist's medical necessity letter. First step today: Have your hematologist/

How to Get Duopa Covered by Aetna CVS Health in North Carolina: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Duopa Covered by Aetna CVS Health in North Carolina Duopa (carbidopa/levodopa enteral) requires prior authorization from Aetna CVS Health and typically involves step therapy requirements. To get coverage approved in North Carolina: 1. Document failed oral therapy - Your neurologist must show you've tried

How to Get Elaprase (Idursulfase) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Elaprase (Idursulfase) Covered by Cigna in North Carolina Eligibility: Cigna covers Elaprase for Hunter syndrome (MPS II) when you have confirmed enzymatic deficiency AND genetic testing showing IDS gene mutations. Fastest approval path: Submit prior authorization with both biochemical and molecular diagnostic proof, weight-based dosing calculations, and

How to Get Chenodal (Chenodiol) Covered by Blue Cross Blue Shield in New Jersey: Timeline, Forms & Appeal Guide

Answer Box: Getting Chenodal Covered in New Jersey Chenodal (chenodiol) requires prior authorization from Blue Cross Blue Shield in New Jersey. The fastest path to approval: 1) Have your doctor submit a PA request through Horizon's provider portal with imaging confirming radiolucent gallstones and documentation of surgical ineligibility,

How to Get Cabometyx (Cabozantinib) Covered by Cigna in North Carolina: Complete Appeals Guide

Answer Box: Getting Cabometyx Covered by Cigna in North Carolina Cigna requires prior authorization for Cabometyx (cabozantinib) with specific documentation: FDA-approved diagnosis, prior therapy failures, and prescriber attestation. Submit the Cigna PA form with complete clinical records. If denied, you have 180 days for internal appeals, then 120 days for

Denied for Brensocatib (BRINSUPRI) by UnitedHealthcare in Georgia? How to Appeal (Templates & Timelines)

Answer Box: UnitedHealthcare requires prior authorization for Brensocatib (BRINSUPRI) with likely step therapy requirements. If denied, you have 180 days to appeal internally, then 60 days for Georgia's external review. Start by gathering your denial letter, medical records, and a letter of medical necessity from your doctor. Submit

How to Get Jynarque (Tolvaptan) Covered by Cigna in Virginia: Complete PA Guide and Appeals Process

Quick Answer: Getting Jynarque Covered by Cigna in Virginia Fastest path to approval: Your nephrologist must document ADPKD with rapid progression (Mayo Class 1C-1E or eGFR decline ≥3.0 mL/min/1.73 m²/year), baseline eGFR ≥25, and complete REMS enrollment before submitting Cigna's prior authorization form.

Complete Guide: Getting Imbruvica (ibrutinib) Covered by UnitedHealthcare in Pennsylvania - Prior Authorization, Appeals, and Success Strategies

Answer Box: Your Path to Imbruvica Coverage in Pennsylvania Getting Imbruvica (ibrutinib) covered by UnitedHealthcare in Pennsylvania requires prior authorization, proper diagnosis documentation, and often step therapy compliance. Most approvals take 5-15 business days with complete submissions. If denied, Pennsylvania's new external review program has overturned 50% of

How to Get Rezlidhia (olutasidenib) Covered by Aetna CVS Health in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Rezlidhia Coverage Getting Rezlidhia (olutasidenib) covered by Aetna CVS Health in Michigan requires prior authorization with documented IDH1 mutation, hematology/oncology specialist prescription, and evidence of prior therapy failures. Start by having your oncologist submit a PA request through Aetna's provider portal with

Getting Prolastin-C Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization, Appeals, and State External Review

Answer Box: Prolastin-C Coverage with Blue Cross Blue Shield in Virginia Blue Cross Blue Shield Virginia requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) for alpha-1 antitrypsin deficiency. Coverage requires documented severe AATD (like Pi*ZZ genotype), clinical evidence of emphysema, and lung function tests showing moderate impairment (typically FEV1 35-60%